The World Health Organization says that none of the vaccine candidates have so far demonstrated a "clear signal" of efficacy against COVID-19
According to the results of Russia's 'Sputnik V' COVID-19 vaccine candidate published in The Lancet journal, most common adverse effects of the vaccine were pain at...
According to the researchers, global samples show SARS-CoV-2 to be less diverse than other viruses such as HIV, influenza and dengue. This may aid in the...
According to experts, the aim behind Covax (COVID-19 Vaccines Global Access Facility) is to prevent hoarding and focus on vaccinating high-risk people in every country
The blood samples collected from the volunteers who received the vaccine were to ascertain how effective the vaccine was in terms of the level of antibodies...
World Health Organisation's Chief Scientist Soumya Swaminathan said the focus needs to be on global collaboration when dealing with the virus diagnostics, therapeutics, transmission and vaccine...
The second phase trial of Oxford University and Serum Institute’s COVID-19 vaccine has begun in Pune, as the vaccine candidate administered to two volunteers at Bharati...
Human trials for potential COVID-19 vaccine begin in India. A total of 1,600 eligible participants of more than or equal to 18 years of age will...
The COVAX global vaccines facility is a program designed to pool funds from wealthier countries and non-profits to develop a COVID-19 vaccine and distribute it equitably...
The National Expert Group on COVID-19 Vaccine Administration met with leading domestic vaccine manufacturers, to seek the present status of the various Indian coronavirus vaccine candidates
Union Minister of State for Health Ashwini Kumar Choubey informed that if India succeeds in getting a vaccine against COVID-19, our COVID warriors will be the...
According to the Vladimir Putin, President of Russia, the vaccine developed by Moscow's Gamaleya Institute is safe and has even been administered to one of his...